Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    February 2025
  1. REBOLLEDO MA, Knott-Craig CJ, Corson AH, Phillip R, et al
    Right Ventricular Endomyocardial Fibrosis with an Unguarded Tricuspid Valve - Surgical Management of a 9-year-old with Severe Right Heart Failure.
    J Thorac Cardiovasc Surg. 2025 Feb 4:S0022-5223(25)00096.
    PubMed    


  2. MOELLER CM, Rubinstein G, Oren D, Valledor AF, et al
    Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center.
    J Thorac Cardiovasc Surg. 2025;169:650-657.
    PubMed     Abstract available


    September 2024
  3. BRLECIC PE, Ghanta RK
    Commentary: Building bridges to recovery in patients with ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;168:e89-e90.
    PubMed    


  4. HEIMA D, Takeda M, Tabata Y, Minatoya K, et al
    Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;168:e72-e88.
    PubMed     Abstract available


    August 2024

  5. Discussion to: Outcome of patients supported with HeartMate 3 after extracorporeal life support: On behlaf of the Durable Mechanical Circulatory Support After Extracorporeal Life Support Study Group.
    J Thorac Cardiovasc Surg. 2024;168:579-580.
    PubMed    


    July 2024

  6. Discussion to: Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:145-146.
    PubMed    


  7. TANG PC, Millar J, Noly PE, Sicim H, et al
    Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:133-144.
    PubMed     Abstract available


    June 2024
  8. NGUYEN A, Schaff HV
    Is Transplantation the Only Option for Diastolic Heart Failure?
    J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00525.
    PubMed    


  9. GUZMAN-GOMEZ A, Greenberg JW, Dani A, Villa C, et al
    In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
    J Thorac Cardiovasc Surg. 2024;167:2206-2214.
    PubMed     Abstract available


  10. MOVAHEDI F, Pagani FD, Antaki JF
    In search of similarity in adverse events journeys of patients with left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;167:2147-2156.
    PubMed     Abstract available


    May 2024

  11. Discussion to: Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1564-1565.
    PubMed    


  12. GREENBERG JW, Kulshrestha K, Guzman-Gomez A, Fields K, et al
    Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1556-1563.
    PubMed     Abstract available


  13. KONSTANTINOV IE, Davies B
    Durable ventricular assist device implantation in a child after double switch operation.
    J Thorac Cardiovasc Surg. 2024;167:1566-1569.
    PubMed    


  14. SILVESTRY SC
    Commentary: Tricuspid repair and left ventricular assist device: A new baseline.
    J Thorac Cardiovasc Surg. 2024;167:1821-1822.
    PubMed    


  15. SIMPSON MT, Ning Y, Kurlansky P, Colombo PC, et al
    Outcomes of treatment for deep left ventricular assist device infection.
    J Thorac Cardiovasc Surg. 2024;167:1824-1832.
    PubMed     Abstract available


    April 2024
  16. BLEIWEIS MS, Philip J, Peek GJ, Jacobs JP, et al
    Commentary: Challenges associated with long-term implantable ventricular assist device support in children.
    J Thorac Cardiovasc Surg. 2024;167:1429-1430.
    PubMed    


  17. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    PubMed     Abstract available


    March 2024
  18. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed     Abstract available


  19. AZIZGOLSHANI N, Takeda K
    Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:1060-1061.
    PubMed    


    February 2024
  20. GOSEV I, Pham DT, Um JY, Anyanwu AC, et al
    Ventricular Assist Device using a Thoracotomybased Implant Technique: Multi-center HeartMate 3 SWIFT Study.
    J Thorac Cardiovasc Surg. 2024 Feb 15:S0022-5223(24)00179.
    PubMed     Abstract available


  21. SINGH SK, Hassanein M, Ning Y, Wang C, et al
    Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:535-543.
    PubMed     Abstract available


  22. VINOGRADSKY A, Ning Y, Kurlansky P, Kirschner M, et al
    Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy.
    J Thorac Cardiovasc Surg. 2024;167:731-743.
    PubMed     Abstract available


  23. DIMAGLI A, Worku B, Gaudino M
    Commentary: Minimally invasive left ventricular assist device implantation: Did we forget the valve?
    J Thorac Cardiovasc Surg. 2024;167:744-745.
    PubMed    


    January 2024
  24. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
    Total artificial heart implantation as a bridge to transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024;167:205-214.
    PubMed     Abstract available


    December 2023
  25. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
    Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
    PubMed     Abstract available



  26. Discussion to: Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.
    J Thorac Cardiovasc Surg. 2023 Dec 2:S0022-5223(23)01088.
    PubMed    


  27. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
    Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
    J Thorac Cardiovasc Surg. 2023;166:1756-1763.
    PubMed     Abstract available


  28. JOHN R, Kanwar MK, Cleveland JC Jr, Uriel N, et al
    Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial
    J Thorac Cardiovasc Surg. 2023;166:1684-1694.
    PubMed     Abstract available


    October 2023
  29. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available


  30. DECAMPLI WM
    Commentary: Is machine learning needed to understand that heart failure is a risk in adult congenital cardiac surgery?
    J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00977.
    PubMed    


  31. FENG I, Wang AS, Takeda K, Topkara VK, et al
    Simultaneous Heart-Kidney Transplant Compared to Heart Transplant Alone in Non-Dialysis Dependent Patients with Borderline Renal Function.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00960.
    PubMed     Abstract available


  32. KONSTANTINOV IE, Brizard CP, Davies B
    Severe aortic valve insufficiency in infants on durable ventricular assist device support.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00914.
    PubMed    


  33. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available


  34. MOAZAMI N, Smith D
    Commentary: Direct cardiac compression device for biventricular support: If we put lipstick on a pig, is it still a pig?
    J Thorac Cardiovasc Surg. 2023;166:1130-1131.
    PubMed    


    September 2023
  35. GRIFFETH EM, Stephens EH, Dearani JA, Shreve JT, et al
    Impact of Heart Failure on Reoperation in Adult Congenital Heart Disease: An Innovative Machine Learning Model.
    J Thorac Cardiovasc Surg. 2023 Sep 28:S0022-5223(23)00871.
    PubMed     Abstract available


  36. SAEED D, Stark C, Otto W, Loforte A, et al
    Outcome of Patients supported with HeartMate 3 after Extra-corporeal Life Support. On behalf of Durable MCS after ECLS Study Group.
    J Thorac Cardiovasc Surg. 2023 Sep 7:S0022-5223(23)00763.
    PubMed     Abstract available


    August 2023
  37. KING CL, Onohara D, Tom SK, Silverman M, et al
    Transapical Ventricular Reshaping Reduces Functional Mitral Regurgitation and Improves Ventricular Function in a Preclinical Model of Ischemic Cardiomyopathy.
    J Thorac Cardiovasc Surg. 2023 Aug 17:S0022-5223(23)00724.
    PubMed     Abstract available


  38. ZHOU S, Yang G, Zhang M, Pienta M, et al
    Mortality following durable left ventricular assist device implantation by timing and type of first infection.
    J Thorac Cardiovasc Surg. 2023;166:570-579.
    PubMed     Abstract available


    July 2023
  39. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    


    June 2023
  40. KULSHRESTHA K, Greenberg JW, Kennedy JT 3rd, Hogue S, et al
    National Experience with Pediatric Surgical Aortic Valve Repair - A Pediatric Health Information System Analysis.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00538.
    PubMed     Abstract available


  41. MALAS J, Chen Q, Emerson D, Gill G, et al
    Socioeconomic Disparities in Mid-Term Outcomes After Repair for Degenerative Mitral Regurgitation.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00534.
    PubMed     Abstract available


  42. LIU R, Li S, Yan J, Yan F, et al
    Fate of Transposition of the Great Arteries with Pulmonary Stenosis After Double-Root Translocation, Rastelli, and Reparation a l'Etage Ventriculaire.
    J Thorac Cardiovasc Surg. 2023 Jun 7:S0022-5223(23)00455.
    PubMed     Abstract available


  43. PIENTA MJ, Noly PE, Janda AM, Tang PC, et al
    Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device.
    J Thorac Cardiovasc Surg. 2023;165:2126-2131.
    PubMed    


  44. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available


  45. KILCOYNE MF, Blanding WM, Kilic A
    Commentary: Left ventricular assist device implantation and failure to rescue: New insights and familiar challenges.
    J Thorac Cardiovasc Surg. 2023;165:2124-2125.
    PubMed    


    April 2023
  46. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed     Abstract available


    March 2023
  47. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    


  48. YOUNG BAC, Tang PC
    Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?
    J Thorac Cardiovasc Surg. 2023;165:1125-1126.
    PubMed    


  49. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available


  50. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    


    January 2023
  51. PAGANI FD
    Commentary: Lack of benefit of tricuspid valve intervention with left ventricular assist device implantation? It's all in the details.
    J Thorac Cardiovasc Surg. 2023 Jan 21:S0022-5223(23)00084.
    PubMed    


    December 2022
  52. BLANDING W, Kilic A
    Demise of HVAD: The only constant is change.
    J Thorac Cardiovasc Surg. 2022;164:1945-1947.
    PubMed    


  53. BOSSERS GPL, Gunthel M, van der Feen DE, Hagdorn QAJ, et al
    Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load.
    J Thorac Cardiovasc Surg. 2022;164:e493-e510.
    PubMed     Abstract available


  54. BALACHANDRAN I, Frazier OH, Rogers JG
    Doing the wrong thing for the right reasons: The demise of the HVAD.
    J Thorac Cardiovasc Surg. 2022;164:1937-1941.
    PubMed    


  55. KIRKLIN JK
    Commentary: Collateral impact of the HVAD decision and the path forward.
    J Thorac Cardiovasc Surg. 2022;164:1942-1943.
    PubMed    


  56. BROWN JA, Aranda-Michel E, Kilic A, Serna-Gallegos D, et al
    The impact of pulmonary artery catheter use in cardiac surgery.
    J Thorac Cardiovasc Surg. 2022;164:1965-1973.
    PubMed     Abstract available


  57. FARSKY PS, White J, Al-Khalidi HR, Sueta CA, et al
    Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
    J Thorac Cardiovasc Surg. 2022;164:1890-1899.
    PubMed     Abstract available


  58. HRYTSYNA Y, Kneissler S, Kaufmann F, Muller M, et al
    Experience with a standardized protocol to predict successful explantation of left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1922-1930.
    PubMed     Abstract available


  59. JAWAD K, Sipahi F, Koziarz A, Huhn S, et al
    Less-invasive ventricular assist device implantation: A multicenter study.
    J Thorac Cardiovasc Surg. 2022;164:1910-1918.
    PubMed     Abstract available


  60. BROWN JA, Sultan I
    Commentary: Sometimes less is more: The minimally invasive argument for ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1920-1921.
    PubMed    


    November 2022
  61. MENDIOLA PLA M, Chiang Y, Nicoara A, Poehlein E, et al
    Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial.
    J Thorac Cardiovasc Surg. 2022 Nov 16:S0022-5223(22)01243.
    PubMed     Abstract available


  62. CHO J, Fuentes-Baldemar AA, Tunuguntla HP, Spinner JA, et al
    Outcomes of temporary ventricular assist device: A pediatric institutional experience over 25 years.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01164.
    PubMed     Abstract available


  63. SILVESTRY SC
    Commentary: Left ventricular assist device complications after heart transplantation: Then and now.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01173.
    PubMed    


  64. BLANDING WM, Kilic A
    Commentary: Durable left ventricular assist device infections: A call to arms.
    J Thorac Cardiovasc Surg. 2022;164:1570-1571.
    PubMed    


  65. LIKOSKY DS, Yang G, Zhang M, Malani PN, et al
    Interhospital variability in health care-associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries.
    J Thorac Cardiovasc Surg. 2022;164:1561-1568.
    PubMed     Abstract available


    October 2022
  66. HAYWARD C, Adachi I, Baudart S, Davis E, et al
    Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.
    J Thorac Cardiovasc Surg. 2022;164:1120-1137.
    PubMed     Abstract available


  67. GOUTALLIER CS, Buratto E, Schulz A, Hu T, et al
    Repair of complete atrioventricular septal defect between 2 and 3.5 kilograms: Defining the limits of safe repair.
    J Thorac Cardiovasc Surg. 2022;164:1167-1175.
    PubMed     Abstract available


  68. TOMINAGA Y, Taira M, Watanabe T, Hasegawa M, et al
    Clinical significance of diastolic dysfunction on outcomes of pulmonary valve replacement for pulmonary insufficiency.
    J Thorac Cardiovasc Surg. 2022;164:1156-1164.
    PubMed     Abstract available


  69. TOSO A, Castelvecchio S, Menicanti L, Volpe M, et al
    Prognostic value of natriuretic peptides and restrictive filling pattern before surgical ventricular restoration.
    J Thorac Cardiovasc Surg. 2022;164:1092-1101.
    PubMed     Abstract available


    September 2022
  70. SHAH AS
    Commentary: When a ventricular assist device is just not enough.
    J Thorac Cardiovasc Surg. 2022;164:978.
    PubMed    


    August 2022
  71. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available


  72. BEDZRA EKS, Adachi I, Peng DM, Amdani S, et al
    Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs Databases.
    J Thorac Cardiovasc Surg. 2022;164:353-364.
    PubMed     Abstract available


    June 2022
  73. SALERNO CT, Hayward C, Hall S, Goldstein D, et al
    HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
    J Thorac Cardiovasc Surg. 2022;163:2120-2127.
    PubMed     Abstract available


  74. SHAFII A, Liao K, Ghanta RK
    Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall.
    J Thorac Cardiovasc Surg. 2022;163:2129-2130.
    PubMed    


  75. DEO SV, Sundaram V, Wilson B, Sahadevan J, et al
    Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database.
    J Thorac Cardiovasc Surg. 2022;163:2096-2103.
    PubMed     Abstract available


    April 2022
  76. GAUDINO M, Castelvecchio S, Rahouma M, Robinson NB, et al
    Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial.
    J Thorac Cardiovasc Surg. 2022 Apr 26. pii: S0022-5223(22)00493.
    PubMed     Abstract available


  77. MAH KE, Morales DLS
    Commentary: The Vulcan mind MELD-XI.
    J Thorac Cardiovasc Surg. 2022;163:1477-1478.
    PubMed    


    February 2022
  78. KIM HR, Kim WK, Kim JK, Kim HJ, et al
    Prognostic impact of the E/e' ratio in patients with chronic severe aortic regurgitation undergoing aortic valve replacement.
    J Thorac Cardiovasc Surg. 2022 Feb 2. pii: S0022-5223(22)00114.
    PubMed     Abstract available


  79. ZHU Y, Shudo Y, Lingala B, Baiocchi M, et al
    Outcomes after heart retransplantation: A 50-year single-center experience.
    J Thorac Cardiovasc Surg. 2022;163:712-720.
    PubMed     Abstract available


  80. BIANCO V, Kilic A, Yousef S, Serna-Gallegos D, et al
    The long-term impact of postoperative atrial fibrillation after cardiac surgery.
    J Thorac Cardiovasc Surg. 2022 Feb 1. pii: S0022-5223(22)00103.
    PubMed     Abstract available


    January 2022
  81. ALSOUFI B
    Commentary: Heart transplantation listing for children with significant renal insufficiency: The need for a paradigm shift.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00006.
    PubMed    


  82. NIKOLOVA A, Youn JC, Kobashigawa JA
    Commentary: The anticlimax of the left ventricular assist devices-associated antibodies.
    J Thorac Cardiovasc Surg. 2022;163:136-137.
    PubMed    


  83. BAKIR NH, Finnan MJ, MacGregor RM, Schilling JD, et al
    Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;163:124-134.
    PubMed     Abstract available


    November 2021
  84. ELGHARABLY H, Ibrahim A, Rosinski B, Thuita L, et al
    Right heart failure and patient selection for isolated tricuspid valve surgery.
    J Thorac Cardiovasc Surg. 2021 Nov 25. pii: S0022-5223(21)01657.
    PubMed     Abstract available


  85. MENNANDER AA
    Commentary: Preventive treatment of right-sided heart failure before adulthood?
    J Thorac Cardiovasc Surg. 2021 Nov 4. pii: S0022-5223(21)01533.
    PubMed    


  86. LI S, Zimpfer D, Mahr C
    Commentary: Transcending acceptable, moving toward optimal: Standardizing surgical configurations of ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:1566-1567.
    PubMed    


  87. KASINPILA P, Kong S, Fong R, Shad R, et al
    Use of patient-specific computational models for optimization of aortic insufficiency after implantation of left ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:1556-1563.
    PubMed     Abstract available


    October 2021
  88. YANG B, Caceres J, Farhat L, Le T, et al
    Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes.
    J Thorac Cardiovasc Surg. 2021;162:1049-1059.
    PubMed     Abstract available


    September 2021
  89. BRAHMBHATT DH, Rao V
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.
    PubMed    


  90. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available


  91. RAJAGOPAL K, Cheema FH, Omer S
    Commentary: Heart failure and the problem of causality.
    J Thorac Cardiovasc Surg. 2021 Sep 8. pii: S0022-5223(21)01300.
    PubMed    


    August 2021
  92. PERRY T, Morales DLS
    Commentary: Promise with pulsatility? Early bridging of high-risk patients with single-ventricle physiology with a ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:415-416.
    PubMed    


  93. SILVESTRY SC
    Commentary: Better pumps, better patients, better physicians? Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:612-613.
    PubMed    


  94. MOON J, Adachi I
    Commentary: Ventricular assist device support in an early infancy with single ventricle: Transformation from salvage to elective.
    J Thorac Cardiovasc Surg. 2021;162:416-417.
    PubMed    


  95. LEE MM, Honjo O
    Commentary: How to VAD to avoid BAD in high-risk single ventricle.
    J Thorac Cardiovasc Surg. 2021;162:414-415.
    PubMed    


  96. MILANO CA
    Commentary: Managing the native heart in patients supported with durable left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2021;162:613-614.
    PubMed    


  97. KILIC A
    Commentary: Left ventricular assist device therapy: The time is now.
    J Thorac Cardiovasc Surg. 2021;162:614-615.
    PubMed    


  98. DESHPANDE S, Alsoufi B
    Meeting needs-pushing boundaries: Mechanical circulatory support in children; year in review.
    J Thorac Cardiovasc Surg. 2021;162:400-404.
    PubMed    


  99. SHAFFER A, Cogswell R, John R
    Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:605-611.
    PubMed    


    July 2021
  100. ALSOUFI B
    Commentary: Mitochondrial transplantation for myocardial failure, marvel remedy or wishful thinking?
    J Thorac Cardiovasc Surg. 2021;162:e125-e126.
    PubMed    


  101. ATLURI P, Balsam LB
    Invited Expert Opinion papers on mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021;162:140-142.
    PubMed    


    June 2021
  102. LEE SH, Choi KH, Song YB, Jeong DS, et al
    Comprehensive assessment of heart failure in patients with preserved ejection fraction undergoing coronary bypass grafting.
    J Thorac Cardiovasc Surg. 2021 Jun 19. pii: S0022-5223(21)00980.
    PubMed     Abstract available


  103. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.
    PubMed    


  104. BENAZZO A, Bajorek L, Morscher A, Schrutka L, et al
    Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 1. pii: S0022-5223(21)00879.
    PubMed     Abstract available


    May 2021
  105. DESHPANDE S, Sparks JD, Alsoufi B
    Pediatric heart transplantation: Year in review 2020.
    J Thorac Cardiovasc Surg. 2021 May 3. pii: S0022-5223(21)00758.
    PubMed    


    April 2021
  106. BAKAEEN FG, Gaudino M, Whitman G, Doenst T, et al
    2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.
    J Thorac Cardiovasc Surg. 2021 Apr 30. pii: S0022-5223(21)00736.
    PubMed    


  107. TIMEK TA
    Commentary: The pneumatic para-trouper.
    J Thorac Cardiovasc Surg. 2021;161:1467-1468.
    PubMed    


  108. VILLA CR, Morales DLS
    Commentary: Rejuvenation of a trusted tool.
    J Thorac Cardiovasc Surg. 2021;161:1466-1467.
    PubMed    


  109. KIRKLIN JK
    Commentary: Adult support with a pulsatile VAD: Reawakening of a bygone era?
    J Thorac Cardiovasc Surg. 2021;161:1465-1466.
    PubMed    


    March 2021
  110. FERRARIS VA
    Commentary: Benefits of SGLT2 inhibition in heart failure: A bellwether for importance of other metabolic pathways.
    J Thorac Cardiovasc Surg. 2021 Mar 27. pii: S0022-5223(21)00554.
    PubMed    


  111. AMBROSIO G, Mattioli R, Carluccio E
    Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism.
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00416.
    PubMed    


  112. LAZAR HL
    Commentary: SGLT2 inhibitors reduce mortality and heart failure in patients with type 2 diabetes mellitus-is metabolic reprogramming the mechanism for these favorable outcomes?
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00415.
    PubMed    


  113. MANN PA, Lehrke M
    Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition?
    J Thorac Cardiovasc Surg. 2021 Mar 3. pii: S0022-5223(21)00410.
    PubMed    


    February 2021
  114. CASTELVECCHIO S, Frigelli M, Sturla F, Milani V, et al
    Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: A 3-dimensional ultrasound analysis.
    J Thorac Cardiovasc Surg. 2021 Feb 26. pii: S0022-5223(21)00381.
    PubMed     Abstract available


  115. SOLTESZ EG
    Commentary: To fix or not to fix? That is the question for mitral and aortic valve surgery during left ventricular assist devices implantation.
    J Thorac Cardiovasc Surg. 2021 Feb 18. pii: S0022-5223(21)00344.
    PubMed    


  116. MELEHY A, Sanchez JE, Nemeth SK, Kurlansky PA, et al
    National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00213.
    PubMed     Abstract available


    January 2021
  117. HAWKINS RB, Mehaffey JH
    Commentary: Is heart failure with moderately reduced ejection fraction a useful classification for cardiac surgery?
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00179.
    PubMed    


  118. DEO SV, Sundaram V, Sahadevan J, Selvaganesan P, et al
    Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00132.
    PubMed     Abstract available


    December 2020
  119. HIRJI SA, Cote CL, Javadikasgari H, Malarczyk A, et al
    Atrial functional versus ventricular functional mitral regurgitation: Prognostic implications.
    J Thorac Cardiovasc Surg. 2020 Dec 31. pii: S0022-5223(20)33453.
    PubMed     Abstract available


  120. TANAKA Y, Nakajima T, Fischer I, Wan F, et al
    The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.
    J Thorac Cardiovasc Surg. 2020;160:1490-1500.
    PubMed     Abstract available


    November 2020
  121. RIGGS KW, Morales DLS, Zafar F
    Commentary: Is two ever better than one in pediatric ventricular assist device support? The controversy continues.
    J Thorac Cardiovasc Surg. 2020;160:1309-1310.
    PubMed    


    September 2020
  122. SILVESTRY SC
    Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.
    J Thorac Cardiovasc Surg. 2020 Sep 9. pii: S0022-5223(20)32581.
    PubMed    


  123. SOLTESZ EG
    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.
    PubMed    


  124. ONOHARA D, Corporan DM, Kono T, Kumar S, et al
    Ventricular reshaping with a beating heart implant improves pump function in experimental heart failure.
    J Thorac Cardiovasc Surg. 2020 Sep 3. pii: S0022-5223(20)32535.
    PubMed     Abstract available


  125. BANSAL A, Goldstein D, Schettle S, Pepitone S, et al
    Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
    J Thorac Cardiovasc Surg. 2020 Sep 2. pii: S0022-5223(20)32490.
    PubMed    


    July 2020
  126. KIRKLIN JK
    Commentary: Absence of ventricular assist device-related risk for rejection after heart transplantation: Good news given the "new normal".
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32053.
    PubMed    


    February 2020
  127. SILVER SA, Long J, Zheng Y, Goldstone AB, et al
    Outcomes after left ventricular assist device implantation in patients with acute kidney injury.
    J Thorac Cardiovasc Surg. 2020;159:477-486.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.